Human cytomegalovirus neutralising antibodies and use thereof

Details for Australian Patent Application No. 2008204258 (hide)

Owner Institute for Research in Biomedicine

Inventors MacAgno, Annalisa; Lanzavecchia, Antonio

Agent EF WELLINGTON & CO

Pub. Number AU-B-2008204258

PCT Pub. Number WO2008/084410

Priority 0700133.2 04.01.07 GB

Filing date 3 January 2008

Wipo publication date 17 July 2008

Acceptance publication date 6 September 2012

International Classifications

C07K 16/08 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from viruses

A61K 39/42 Medicinal preparations containing antigens or antibodies - viral

A61P 31/22 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

Event Publications

20 August 2009 PCT application entered the National Phase

  PCT publication WO2008/084410 Priority application(s): WO2008/084410

1 March 2012 Assignment before Grant

  HUMABS LLC The application has been assigned to Institute for Research in Biomedicine

6 September 2012 Application Accepted

  Published as AU-B-2008204258

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008204259-Modified saccharides

2008204257-Means for identifying a strain isolated from a clinical sample at the species and/or subspecies level